Trial Profile
A pilot clinical study investigating intranasal naloxone
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Dec 2017
Price :
$35
*
At a glance
- Drugs Naloxone (Primary)
- Indications Opioid-related disorders
- Focus Adverse reactions; Pharmacokinetics
- 15 Dec 2017 New trial record
- 11 Dec 2017 Results published in the Media Release